Global Survey Reports Perceived Disparities in Diabetes Drug Access Tags Rapid acting short acting Long acting α-Glucosidase inhibitors SGLT-2 Inhibitor Read more about Global Survey Reports Perceived Disparities in Diabetes Drug Access
Randomized Trial Evaluates Open-Source Automated Insulin Delivery Without Meal Announcement in Adults With Type 1 Diabetes Tags Rapid acting short acting Long acting Insulin Pumps Read more about Randomized Trial Evaluates Open-Source Automated Insulin Delivery Without Meal Announcement in Adults With Type 1 Diabetes
Insulin Dose Reduction Influenced Glycemia More Than Insulin Type in T1D Tags Rapid acting Read more about Insulin Dose Reduction Influenced Glycemia More Than Insulin Type in T1D
EMR-Based Insulin Algorithm Improves Inpatient Glycemia Tags Rapid acting short acting Intermediate acting Long acting Read more about EMR-Based Insulin Algorithm Improves Inpatient Glycemia
Insulin Pen Education Boosts Diabetes Adherence Tags Insulin Pens Long acting Rapid acting short acting Read more about Insulin Pen Education Boosts Diabetes Adherence
STAR Protocol Masters Glycemic Control in ICU Tags FBS Hyperglycemia hyperosmolar state Hyperglycemia hyperosmolar state hBA1c Rapid acting short acting Long acting Read more about STAR Protocol Masters Glycemic Control in ICU
Immune Checkpoint Inhibitors-Induced T1DM Risk Factors Identified in Large Cohort Tags Diabetic Nephropathy Long acting Read more about Immune Checkpoint Inhibitors-Induced T1DM Risk Factors Identified in Large Cohort
Insulin Pump Jump-Start Works Better With Diabetes Oral Medications Early On Tags Insulin Pumps Read more about Insulin Pump Jump-Start Works Better With Diabetes Oral Medications Early On
Hepatocellular Carcinoma Risk Declines With GLP-1RA Use Compared With Insulin in Diabetes Read more about Hepatocellular Carcinoma Risk Declines With GLP-1RA Use Compared With Insulin in Diabetes
Once-Daily iGlarLixi Maintains Glycemic Control While Reducing Treatment Burden in T2DM Read more about Once-Daily iGlarLixi Maintains Glycemic Control While Reducing Treatment Burden in T2DM